Nicole Markwick1, Lianping Ti1, Cody Callon2, Cindy Feng3, Evan Wood4, Thomas Kerr4. 1. British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. 2. British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada. 3. School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 4. British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
BACKGROUND: People who inject drugs (IDU) face unique systemic, social and individual barriers to conventional HIV voluntary counselling and testing (VCT) programmes. Peer-delivered approaches represent a possible alternative to improve rates of testing among this population. METHODS: Cross-sectional data from a prospective cohort of IDU in Vancouver, Canada, were collected between December 2011 and May 2012. Bivariate statistics and multivariate logistic regression were used to identify the prevalence of and factors associated with willingness to receive peer-delivered VCT. RESULTS: Of 600 individuals, 51.5% indicated willingness to receive peer-delivered pretest counselling, 40.7% to receive peer-delivered rapid HIV testing and 42.8% to receive peer-delivered post-test counselling. Multivariate analyses found significant positive associations between willingness for pretest counselling and having used Vancouver's supervised injection facility, Insite, or being a member of VANDU (a local drug user organisation) (all p<0.05). Daily crack smoking and having used Insite were positively associated with willingness to receive peer-delivered HIV testing (p<0.05). Willingness to receive peer-delivered post-test counselling was positively associated with male gender, daily crack smoking, having used Insite and being a member of VANDU (p<0.05). CONCLUSIONS: While not universally acceptable, peer-delivered VCT approaches may improve access to HIV testing among IDU. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND:People who inject drugs (IDU) face unique systemic, social and individual barriers to conventional HIV voluntary counselling and testing (VCT) programmes. Peer-delivered approaches represent a possible alternative to improve rates of testing among this population. METHODS: Cross-sectional data from a prospective cohort of IDU in Vancouver, Canada, were collected between December 2011 and May 2012. Bivariate statistics and multivariate logistic regression were used to identify the prevalence of and factors associated with willingness to receive peer-delivered VCT. RESULTS: Of 600 individuals, 51.5% indicated willingness to receive peer-delivered pretest counselling, 40.7% to receive peer-delivered rapid HIV testing and 42.8% to receive peer-delivered post-test counselling. Multivariate analyses found significant positive associations between willingness for pretest counselling and having used Vancouver's supervised injection facility, Insite, or being a member of VANDU (a local drug user organisation) (all p<0.05). Daily crack smoking and having used Insite were positively associated with willingness to receive peer-delivered HIV testing (p<0.05). Willingness to receive peer-delivered post-test counselling was positively associated with male gender, daily crack smoking, having used Insite and being a member of VANDU (p<0.05). CONCLUSIONS: While not universally acceptable, peer-delivered VCT approaches may improve access to HIV testing among IDU. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
ADDICTIVE BEHAVIOUR/ADDICTION; DRUG MISUSE; HIV; PUBLIC HEALTH
Authors: Pepijn van Empelen; Gerjo Kok; Nicole M C van Kesteren; Bart van den Borne; Arjan E R Bos; Herman P Schaalma Journal: Soc Sci Med Date: 2003-11 Impact factor: 4.634
Authors: Evan Wood; Thomas Kerr; Robert S Hogg; Anita Palepu; Ruth Zhang; Steffanie A Strathdee; Julio S G Montaner Journal: Drug Alcohol Rev Date: 2006-09
Authors: R S Broadhead; D D Heckathorn; D L Weakliem; D L Anthony; H Madray; R J Mills; J Hughes Journal: Public Health Rep Date: 1998-06 Impact factor: 2.792
Authors: Scott E Kellerman; J Stan Lehman; Amy Lansky; Mark R Stevens; Frederick M Hecht; Andrew B Bindman; Pascale M Wortley Journal: J Acquir Immune Defic Syndr Date: 2002-10-01 Impact factor: 3.731
Authors: Mary B Morris; Bushimbwa Tambatamba Chapula; Benjamin H Chi; Albert Mwango; Harmony F Chi; Joyce Mwanza; Handson Manda; Carolyn Bolton; Debra S Pankratz; Jeffrey S A Stringer; Stewart E Reid Journal: BMC Health Serv Res Date: 2009-01-09 Impact factor: 2.655
Authors: Lisa Lazarus; Sheetal Patel; Ashley Shaw; Sean Leblanc; Christine Lalonde; Manisha Hladio; Kira Mandryk; Cynthia Horvath; William Petrcich; Claire Kendall; Mark W Tyndall Journal: PLoS One Date: 2016-12-02 Impact factor: 3.240
Authors: Bach Xuan Tran; Long Hoang Nguyen; Lan Phuong Nguyen; Cuong Tat Nguyen; Huong Thi Thu Phan; Carl A Latkin Journal: PLoS One Date: 2016-04-05 Impact factor: 3.240